The Doris Duke Operations Research on AIDS Care and Treatment in Africa (ORACTA) program seeks to improve the care and treatment of AIDS patients in resource-limited settings, inform antiretroviral therapy (ART) policy and practice, and improve outcomes of the roll-out and scale-up of ART in Africa.
In sub-Saharan Africa, more than a million people are now on antiretroviral treatment for HIV/AIDS, a 10-fold increase since December 2003; 23 percent of the estimated 4.6 million people in immediate need of ART in sub-Saharan Africa are now receiving treatment. There is, however, only limited knowledge and experience of how best to deliver ART in resource-constrained contexts. The ORACTA program was designed to help support health operations research that can address this knowledge gap.
Since 2005, 30 teams of researchers working in Africa have received ORACTA grants totaling approximately $6 million.
ORACTA grants provide two-year grants of up to $100,000 per year to teams of investigators conducting health operations research on AIDS care and treatment in Africa. Indirect costs are not supported by this award.
New grants are not being offered at this time.
To be notified of future ORACTA competitions, sign up for the Medical Research Program's mailing list.
The program supports a spectrum of health services research, including operations and implementation research, related to AIDS care and treatment in Africa:
Grantees must be investigators who are working with healthcare teams that provide care and treatment to AIDS patients in Africa. The team of investigators must include at least one Co-Investigator who is African and working at an African institution. The Principal Investigator must be affiliated with a U.S. accredited, degree-granting institution; a U.S. academic research institution; or a U.S. charitable institution that is tax-exempt and publicly supported as defined by the U.S. Internal Revenue Code.
The Medical Research Program issues a Request for Proposals for this award competition. An expert panel reviews the proposals based on the criteria listed in the RFP, and recommends to the DDCF the strongest proposals for funding.
June 1, 2007
DDCF announces the results of the 2007 ORACTA competition:
Press Release (38 KB PDF)
Over 70 African and US research partners attended the March 18-19, 2008 ORACTA grantee meeting held in conjunction with the 3rd International Conference on HIV Treatment Adherence at the Hyatt Regency in Jersey City, New Jersey.
In addition to presenting their research, ORACTA grantees also participated in Working Group sessions:
Working Group Discussion Summaries and Meeting Agenda (91 KB PDF)
Email questions about the ORACTA program to ddcf@aibs.org and type ORACTA as the subject line.
Receive notification by email of the latest news and funding opportunities offered by the Medical Research Program:
Sign up now!